Chemical Compound
(2S-(2alpha,3beta(1R*,3R*,4S*)))-6-((2,6-Dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-alpha-D-lyxo-hexopyranosyl-(1->3)-2,6-dideoxy-beta-D-arabino-hexopyranosyl)oxy)-3-(3,4-dihydroxy-1-methyl-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-1(2H)-anthracenone
CAS Registry Number
18378-89-7
Primary record
(2S-(2alpha,3beta(1R*,3R*,4S*)))-6-((2,6-Dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-alpha-D-lyxo-hexopyranosyl-(1->3)-2,6-dideoxy-beta-D-arabino-hexopyranosyl)oxy)-3-(3,4-dihydroxy-1-methyl-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-1(2H)-anthracenone
- 库存
- 6,141 克
- 纯度
- 99.2 %
- CAS
- 18378-89-7
化合物标识与属性
- CAS
- 18378-89-7
- PubChem CID
- 29051
- SMILES
- C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H]2C[C@@H](O[C@@H]([C@H]2O)C)OC3=CC4=CC5=C(C(=O)[C@H]([C@@H](C5)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)O[C@H]7C[C@H]([C@@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@@H]([C@H](O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O
- Canonical SMILES
- CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1
名称与同义词
- mithramycin a
- plicamycin
- Mithramycinum
- Mithramycine
- Mitramicina
- Mitramycin
- Mitramycine
- Mitramycinum
- Plicamicina
- Plicamycine
- Plicamycinum
- Mithracin
- Aureolic acid
- Aurlelic acid
- Aurelic acid
- MITHRAMYCIN
- Mithramycin (USAN
- Plicamycine [French]
- Plicamycinum [Latin]
- Plicamicina [Spanish]
- antibiotic LA-7017
- Antibiotic LA 7017
- Plicamycine [INN-French]
- Plicamycinum [INN-Latin]
- Mithramycine [INN-French]
- Mithramycinum [INN-Latin]
- Mitramicina [INN-Spanish]
- Plicamicina [INN-Spanish]
- AC1L1GN4
- CHEMBL451483
- UNII-NIJ123W41V
- SCHEMBL95305
- Plicamycin [USAN:BAN:INN]
- Plicamycin [USAN:INN:BAN]
- CCRIS 5629
- HSDB 3238
- Plicamycin [USAN:USP:INN:BAN]
- CID29051
- BDBM50103617
- NSC 24559
- PA 144
- C52-H76-O24
- A-2371
- 18378-89-7
- (2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5R,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one
- (2S-(2alpha,3beta(1R*,3R*,4S*)))-6-((2,6-Dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-alpha-D-lyxo-hexopyranosyl-(1->3)-2,6-dideoxy-beta-D-arabino-hexopyranosyl)oxy)-3-(3,4-dihydroxy-1-methyl-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-1(2H)-anthracenone
- 1(2H)-Anthracenone, 6-((2,6-dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-H)-2-((O-2,6-dideoxy-3-C-methyl-beta-D-ribohexopyranosyl-(1,4)-O-2,6-dideoxy-alpha-D-lyxo-hexpyranosyl-(1-3)-2,6-dideoxy-beta-D-arabino-hexpyranosyl)oxy)-3-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-, (2S-alpha,3beta(1R*,3R*4S*)))-
- D-threo-2-Pentulose, 5-deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-.beta.-D-arabino-hexopyranosyl)-.beta.-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-.beta.-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-.beta.-D-lyxo-hexopyranosyl-
- D-threo-2-Pentulose, 5-deoxy-1-C-[(2S,3S)-7-[[2,6-dideoxy-3-O-(2,6-dideoxy-.beta.-D-arabino-hexopyranosyl)-.beta.-D-arabino-hexopyranosyl]oxy]-3-[(O-2,6-dideoxy-3-C-methyl-.beta.-D-ribo-hexopyranosyl-(1?3)-O-2,6-dideoxy-.beta.-D-lyxo-hexopyranosyl-(1?3)-2